TrialCornea2016

Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study.

Eric D Donnenfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.